Targeted News Service

Ropes & Gray Advises AvenCell Therapeutics in $112 Million Series B Funding
October 24, 2024

BOSTON, Massachusetts, Oct. 24 -- Ropes and Gray, a law firm, issued the following news:

Ropes & Gray represented AvenCell Therapeutics in its $112 million Series B funding round led by global life sciences investor Novo Holdings. New investors F-Prime Capital, Eight Roads VenturesJapan, Piper Heartland Healthcare Capital and NYBC Ventures also participated in the round alongside founding investor Blackstone Life Sciences.

AvenCell is a leading clinical-stage cell t . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form